A new paper published in Molecular Cell by senior author Dr. David Andrews suggests a new approach to chemotherapy drugs that may be more effective than current methods. The research shows a new way to target “guardian proteins” that slow down programmed cell death, using switch-like activation by allosteric inhibitors. Read more of the story here.